mRNA |
XMD14-99 |
GDSC1000 |
pan-cancer |
AAC |
0.061 |
0.05 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.05 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.05 |
mRNA |
MI-1 |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.05 |
mRNA |
SL 0101-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.066 |
0.05 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.06 |
mRNA |
BRD-K86535717 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.06 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.06 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.07 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.07 |